Production (Stage)
biote Corp.
BTMD
$3.53
-$0.55-13.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.44% | 6.38% | 4.84% | 3.70% | 8.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.44% | 6.38% | 4.84% | 3.70% | 8.49% |
| Cost of Revenue | -0.14% | 0.58% | -2.33% | -2.66% | 2.27% |
| Gross Profit | 9.35% | 9.02% | 8.25% | 6.74% | 11.49% |
| SG&A Expenses | 17.54% | 13.12% | 13.32% | 12.47% | -42.30% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.62% | 8.20% | 6.85% | 6.17% | -30.43% |
| Operating Income | -8.74% | -0.67% | -2.25% | -4.99% | 205.38% |
| Income Before Tax | 25.60% | 926.02% | 205.44% | 201.22% | 160.88% |
| Income Tax Expenses | -97.75% | -66.96% | -51.47% | 58.46% | 366.88% |
| Earnings from Continuing Operations | 68.19% | 104.63% | 520.68% | 174.03% | 143.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 60.37% | -84.71% | -402.49% | -226.34% | -132.00% |
| Net Income | 217.87% | -67.85% | 282.30% | 118.67% | 176.67% |
| EBIT | -8.74% | -0.67% | -2.25% | -4.99% | 205.38% |
| EBITDA | -6.59% | 1.19% | -1.85% | -4.69% | 211.12% |
| EPS Basic | 479.57% | 140.98% | 186.95% | 117.47% | 119.75% |
| Normalized Basic EPS | 37.61% | -47.84% | -1.87% | -89.24% | 119.51% |
| EPS Diluted | 6,091.95% | 111.17% | 113.99% | 93.79% | 98.77% |
| Normalized Diluted EPS | 25.70% | -49.88% | -52.90% | -91.66% | 129.49% |
| Average Basic Shares Outstanding | 6.05% | 26.72% | 71.63% | 141.78% | 188.52% |
| Average Diluted Shares Outstanding | -6.78% | 3.44% | 27.50% | 54.89% | 63.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.75% | 0.67% | 1.32% | 4.14% | 1.56% |